Published in Nat Methods on October 03, 2010
ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci (2013) 2.98
Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol (2011) 2.18
Optogenetics and thermogenetics: technologies for controlling the activity of targeted cells within intact neural circuits. Curr Opin Neurobiol (2011) 1.55
"Beauty is a light in the heart": the transformative potential of optogenetics for clinical applications in cardiovascular medicine. Trends Cardiovasc Med (2014) 1.47
Optogenetic control of cells and circuits. Annu Rev Cell Dev Biol (2011) 1.40
Color-tuned channelrhodopsins for multiwavelength optogenetics. J Biol Chem (2012) 1.34
Formation and optogenetic control of engineered 3D skeletal muscle bioactuators. Lab Chip (2012) 1.28
A comprehensive multiscale framework for simulating optogenetics in the heart. Nat Commun (2013) 1.27
Computational optogenetics: empirically-derived voltage- and light-sensitive channelrhodopsin-2 model. PLoS Comput Biol (2013) 1.25
Cardiac optogenetics. Am J Physiol Heart Circ Physiol (2013) 1.24
Optical mapping of optogenetically shaped cardiac action potentials. Sci Rep (2014) 1.16
Development of miniaturized walking biological machines. Sci Rep (2012) 1.06
Optogenetics for in vivo cardiac pacing and resynchronization therapies. Nat Biotechnol (2015) 1.02
Mind-controlled transgene expression by a wireless-powered optogenetic designer cell implant. Nat Commun (2014) 0.99
Optogenetic control of cardiomyocytes via viral delivery. Methods Mol Biol (2014) 0.97
Cardiac applications of optogenetics. Prog Biophys Mol Biol (2014) 0.95
Biomedically relevant circuit-design strategies in mammalian synthetic biology. Mol Syst Biol (2013) 0.93
Optical control of excitation waves in cardiac tissue. Nat Photonics (2015) 0.93
Computational Optogenetics: A Novel Continuum Framework for the Photoelectrochemistry of Living Systems. J Mech Phys Solids (2012) 0.92
Bioinformatic and mutational analysis of channelrhodopsin-2 protein cation-conducting pathway. J Biol Chem (2011) 0.92
Optogenetics' promise: pacing and cardioversion by light? Future Cardiol (2014) 0.91
Screening action potentials: the power of light. Front Pharmacol (2011) 0.91
Optogenetics enlightens neuroscience drug discovery. Nat Rev Drug Discov (2015) 0.90
Optogenetics-enabled dynamic modulation of action potential duration in atrial tissue: feasibility of a novel therapeutic approach. Europace (2014) 0.88
Optogenetic control of contractile function in skeletal muscle. Nat Commun (2015) 0.87
Opsin spectral sensitivity determines the effectiveness of optogenetic termination of ventricular fibrillation in the human heart: a simulation study. J Physiol (2016) 0.87
Toward microendoscopy-inspired cardiac optogenetics in vivo: technical overview and perspective. J Biomed Opt (2014) 0.86
Optical pacing of the adult rabbit heart. Biomed Opt Express (2013) 0.86
Photothermic regulation of gene expression triggered by laser-induced carbon nanohorns. Proc Natl Acad Sci U S A (2012) 0.85
See the light: can optogenetics restore healthy heartbeats? And, if it can, is it really worth the effort? Expert Rev Cardiovasc Ther (2013) 0.84
The optogenetic (r)evolution. Mol Genet Genomics (2011) 0.84
Optogenetic pacing in Drosophila melanogaster. Sci Adv (2015) 0.83
Genetic engineering of somatic cells to study and improve cardiac function. Europace (2012) 0.83
A century of optocardiography. IEEE Rev Biomed Eng (2013) 0.83
Optogenetic Control of Heart Rhythm by Selective Stimulation of Cardiomyocytes Derived from Pnmt(+) Cells in Murine Heart. Sci Rep (2017) 0.83
Cardiac Optogenetics: Enhancement by All-trans-Retinal. Sci Rep (2015) 0.82
Direct optical activation of skeletal muscle fibres efficiently controls muscle contraction and attenuates denervation atrophy. Nat Commun (2015) 0.82
Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability. Sci Rep (2015) 0.81
All-optical control of cardiac excitation: combined high-resolution optogenetic actuation and optical mapping. J Physiol (2016) 0.80
Optogenetic determination of the myocardial requirements for extrasystoles by cell type-specific targeting of ChannelRhodopsin-2. Proc Natl Acad Sci U S A (2015) 0.80
Optogenetic versus Electrical Stimulation of Human Cardiomyocytes: Modeling Insights. Biophys J (2015) 0.80
Optical stimulation enables paced electrophysiological studies in embryonic hearts. Biomed Opt Express (2014) 0.80
Functional cardiac imaging by random access microscopy. Front Physiol (2014) 0.79
Computational modeling of cardiac optogenetics: Methodology overview & review of findings from simulations. Comput Biol Med (2015) 0.79
Optogenetics for suppression of cardiac electrical activity in human and rat cardiomyocyte cultures. Neurophotonics (2015) 0.79
Optogenetic approach for functional assays of the cardiovascular system by light activation of the vascular smooth muscle. Vascul Pharmacol (2015) 0.79
Pacing lightly: optogenetics gets to the heart. Nat Methods (2010) 0.79
Re-introduction of transmembrane serine residues reduce the minimum pore diameter of channelrhodopsin-2. PLoS One (2012) 0.79
Anion channelrhodopsins for inhibitory cardiac optogenetics. Sci Rep (2016) 0.78
Arrhythmogenic effects of mutated L-type Ca(2+)-channels on an optogenetically paced muscular pump in Caenorhabditis elegans. Sci Rep (2015) 0.78
Room temperature operable autonomously moving bio-microrobot powered by insect dorsal vessel tissue. PLoS One (2012) 0.78
Optical stimulation for restoration of motor function after spinal cord injury. Mayo Clin Proc (2015) 0.78
Fibrous scaffolds for building hearts and heart parts. Adv Drug Deliv Rev (2015) 0.78
Optogenetic defibrillation terminates ventricular arrhythmia in mouse hearts and human simulations. J Clin Invest (2016) 0.77
MiRNA-1/133a clusters regulate adrenergic control of cardiac repolarization. PLoS One (2014) 0.77
Making better scar: Emerging approaches for modifying mechanical and electrical properties following infarction and ablation. Prog Biophys Mol Biol (2015) 0.77
In vivo imaging of transplanted stem cells in the central nervous system. Curr Opin Genet Dev (2014) 0.76
Optogenetic control of cell signaling pathway through scattering skull using wavefront shaping. Sci Rep (2015) 0.76
Tissue-Engineering for the Study of Cardiac Biomechanics. J Biomech Eng (2016) 0.76
Optogenetic Control of Mouse Outer Hair Cells. Biophys J (2016) 0.75
Fiat lux in understanding cardiac pacing, resynchronization and signalling by way of optogenetics. Cardiovasc Res (2014) 0.75
Scalable Electrophysiological Investigation of iPS Cell-Derived Cardiomyocytes Obtained by a Lentiviral Purification Strategy. J Clin Med (2015) 0.75
Synthetic mechanobiology: engineering cellular force generation and signaling. Curr Opin Biotechnol (2016) 0.75
Modulation of cardiomyocyte activity using pulsed laser irradiated gold nanoparticles. Biomed Opt Express (2016) 0.75
Light-based Approaches to Cardiac Arrhythmia Research: From Basic Science to Translational Applications. Clin Med Insights Cardiol (2016) 0.75
Tissue engineering: Nanoelectronics for the heart. Nat Nanotechnol (2016) 0.75
Chemogenetic stimulation of the hypoglossal neurons improves upper airway patency. Sci Rep (2017) 0.75
BACs to the future: new genetic models for cardiovascular discovery. Cardiovasc Res (2013) 0.75
Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics. PLoS One (2017) 0.75
Bringing new dimensions to drug discovery screening: impact of cellular stimulation technologies. Drug Discov Today (2017) 0.75
Probing Neural Transplant Networks In Vivo with Optogenetics and Optogenetic fMRI. Stem Cells Int (2016) 0.75
Optogenetics design of mechanistically-based stimulation patterns for cardiac defibrillation. Sci Rep (2016) 0.75
Inscribing Optical Excitability to Non-Excitable Cardiac Cells: Viral Delivery of Optogenetic Tools in Primary Cardiac Fibroblasts. Methods Mol Biol (2016) 0.75
Optical control and study of biological processes at the single-cell level in a live organism. Rep Prog Phys (2013) 0.75
From opto- to radio-genetics: A switch in the wavelength. Commun Integr Biol (2012) 0.75
Optogenetics: a novel optical manipulation tool for medical investigation. Int J Ophthalmol (2012) 0.75
Electrophysiological Properties and Viability of Neonatal Rat Ventricular Myocyte Cultures with Inducible ChR2 Expression. Sci Rep (2017) 0.75
Shining Light on the Sprout of Life: Optogenetics Applications in Stem Cell Research and Therapy. J Membr Biol (2016) 0.75
Functional expression and modulation of the L-type Ca2+ current in embryonic heart cells. Pediatr Cardiol (2012) 0.75
Q&A: How can advances in tissue clearing and optogenetics contribute to our understanding of normal and diseased biology? BMC Biol (2017) 0.75
Cardiac optogenetics: using light to monitor cardiac physiology. Basic Res Cardiol (2017) 0.75
Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci (2005) 28.08
'Green mice' as a source of ubiquitous green cells. FEBS Lett (1997) 17.06
Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A (2003) 15.17
Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Curr Biol (2005) 8.01
Embryonic stem cells alone are able to support fetal development in the mouse. Development (1990) 6.37
Electrical stimulation of excitable tissue: design of efficacious and safe protocols. J Neurosci Methods (2005) 6.30
Targeting and readout strategies for fast optical neural control in vitro and in vivo. J Neurosci (2007) 6.28
Calcium cycling and signaling in cardiac myocytes. Annu Rev Physiol (2008) 6.19
Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature (2007) 3.46
Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, I: experimental studies. Circ Res (1999) 3.03
Pluripotent mouse embryonic stem cells are able to differentiate into cardiomyocytes expressing chronotropic responses to adrenergic and cholinergic agents and Ca2+ channel blockers. Differentiation (1991) 2.97
Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res (1994) 2.76
Developmental and adult phenotyping directly from mutant embryonic stem cells. Proc Natl Acad Sci U S A (2007) 2.61
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Virtual electrodes in cardiac tissue: a common mechanism for anodal and cathodal stimulation. Biophys J (1995) 2.08
Properties of new, long-wavelength, voltage-sensitive dyes in the heart. J Membr Biol (2005) 1.26
Roles of electric field and fiber structure in cardiac electric stimulation. Biophys J (1999) 1.24
Intracellular Ca2+ oscillations, a potential pacemaking mechanism in early embryonic heart cells. J Gen Physiol (2007) 1.20
Spatial changes in transmembrane potential during extracellular electrical shocks in cultured monolayers of neonatal rat ventricular myocytes. Circ Res (1996) 1.04
Oct4-induced pluripotency in adult neural stem cells. Cell (2009) 6.50
Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med (2004) 4.59
Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature (2007) 3.46
Monitoring of implanted stem cell migration in vivo: a highly resolved in vivo magnetic resonance imaging investigation of experimental stroke in rat. Proc Natl Acad Sci U S A (2002) 3.27
Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei. Cardiovasc Res (2010) 3.00
Potential risks of bone marrow cell transplantation into infarcted hearts. Blood (2007) 2.97
Chaperone-assisted selective autophagy is essential for muscle maintenance. Curr Biol (2010) 2.45
c-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart. Proc Natl Acad Sci U S A (2012) 2.35
Induction of pluripotency in adult unipotent germline stem cells. Cell Stem Cell (2009) 2.26
Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J Exp Med (2006) 2.23
Myeloid and lymphoid contribution to non-haematopoietic lineages through irradiation-induced heterotypic cell fusion. Nat Cell Biol (2008) 2.17
c-kit expression identifies cardiovascular precursors in the neonatal heart. Proc Natl Acad Sci U S A (2009) 2.06
Ghrelin and des-acyl ghrelin inhibit cell death in cardiomyocytes and endothelial cells through ERK1/2 and PI 3-kinase/AKT. J Cell Biol (2002) 1.97
Pacemaking by HCN channels requires interaction with phosphoinositides. Neuron (2006) 1.84
Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction. J Mol Cell Cardiol (2006) 1.72
Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles. Circulation (2013) 1.72
Association with the auxiliary subunit PEX5R/Trip8b controls responsiveness of HCN channels to cAMP and adrenergic stimulation. Neuron (2009) 1.64
The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet (2007) 1.61
Phosphoinositide 3-kinase gamma-deficient hearts are protected from the PAF-dependent depression of cardiac contractility. Cardiovasc Res (2003) 1.51
Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol (2003) 1.47
Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res (2003) 1.44
Relationships within the Araceae: comparison of morphological patterns with molecular phylogenies. Am J Bot (2011) 1.43
Cardiomyocytes obtained from induced pluripotent stem cells with long-QT syndrome 3 recapitulate typical disease-specific features in vitro. Circ Res (2011) 1.36
Functional complexity of intermediate filament cytoskeletons: from structure to assembly to gene ablation. Int Rev Cytol (2003) 1.28
Universal cardiac induction of human pluripotent stem cells in two and three-dimensional formats: implications for in vitro maturation. Stem Cells (2015) 1.27
Reduced cardiac L-type Ca2+ current in Ca(V)beta2-/- embryos impairs cardiac development and contraction with secondary defects in vascular maturation. Circ Res (2006) 1.24
Types of pollen dispersal units in orchids, and their consequences for germination and fertilization. Ann Bot (2002) 1.23
Modulation of calcium-activated potassium channels induces cardiogenesis of pluripotent stem cells and enrichment of pacemaker-like cells. Circulation (2010) 1.22
Cellular cardiomyoplasty improves survival after myocardial injury. Circulation (2002) 1.21
Intracellular Ca2+ oscillations, a potential pacemaking mechanism in early embryonic heart cells. J Gen Physiol (2007) 1.20
Type II keratins precede type I keratins during early embryonic development. Eur J Cell Biol (2005) 1.18
Concise review: The role of C-kit expressing cells in heart repair at the neonatal and adult stage. Stem Cells (2014) 1.12
Activity of complex III of the mitochondrial electron transport chain is essential for early heart muscle cell differentiation. FASEB J (2004) 1.11
Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc Natl Acad Sci U S A (2008) 1.08
Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL. J Immunol (2007) 1.07
Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation. J Exp Med (2002) 1.07
Establishment and characterization of a mouse embryonic heart slice preparation. Cell Physiol Biochem (2005) 1.05
Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Lab Invest (2012) 1.02
Cardiac hypertrophy is associated with decreased eNOS expression in angiotensin AT2 receptor-deficient mice. Hypertension (2003) 1.01
Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels. Basic Res Cardiol (2013) 1.00
Stem cell implantation in ischemic mouse heart: a high-resolution magnetic resonance imaging investigation. NMR Biomed (2005) 0.98
Cardiac effects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Gln14-ghrelin. Eur J Pharmacol (2003) 0.98
Direct visualization of cell division using high-resolution imaging of M-phase of the cell cycle. Nat Commun (2012) 0.98
Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res (2007) 0.95
Functional expression of the Na+/Ca2+ exchanger in the embryonic mouse heart. J Mol Cell Cardiol (2006) 0.94
Cellular cardiomyoplasty in a transgenic mouse model. Transplantation (2002) 0.93
Lack of laminin gamma1 in embryonic stem cell-derived cardiomyocytes causes inhomogeneous electrical spreading despite intact differentiation and function. Stem Cells (2009) 0.93
Microelectrode arrays: a new tool to measure embryonic heart activity. J Electrocardiol (2004) 0.91
Diversity of Ca2+ signaling in developing cardiac cells. Ann N Y Acad Sci (2006) 0.90
Perlecan is critical for heart stability. Cardiovasc Res (2008) 0.90
Quantitation and functional characterization of neural cells derived from ES cells using nestin enhancer-mediated targeting in vitro. J Cell Sci (2002) 0.89
Minimized cell usage for stem cell-derived and primary cells on an automated patch clamp system. J Pharmacol Toxicol Methods (2013) 0.87
Generation of cardiomyocytes from embryonic stem cells experimental studies. Herz (2002) 0.87
Ca2+ activated K channels-new tools to induce cardiac commitment from pluripotent stem cells in mice and men. Stem Cell Rev (2012) 0.85
Endothelial beta1 integrins regulate sprouting and network formation during vascular development. Development (2010) 0.85
Adult germ line stem cells as a source of functional neurons and glia. Stem Cells (2008) 0.85
Fibroblasts facilitate the engraftment of embryonic stem cell-derived cardiomyocytes on three-dimensional collagen matrices and aggregation in hanging drops. Stem Cells Dev (2010) 0.85
Keratin 5 knockout mice reveal plasticity of keratin expression in the corneal epithelium. Eur J Cell Biol (2006) 0.85
Deletion of integrin linked kinase in endothelial cells results in defective RTK signaling caused by caveolin 1 mislocalization. Development (2013) 0.85
Lentiviral vector mediated thymidine kinase expression in pluripotent stem cells enables removal of tumorigenic cells. PLoS One (2013) 0.85
The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy. Basic Res Cardiol (2014) 0.85
Modulation of L-type Ca(2+) channel current density and inactivation by beta-adrenergic stimulation during murine cardiac embryogenesis. Basic Res Cardiol (2008) 0.84
Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J Electrocardiol (2004) 0.84
Endocannabinoid anandamide mediates hypoxic pulmonary vasoconstriction. Proc Natl Acad Sci U S A (2013) 0.83
Neuronal connexin-36 can functionally replace connexin-45 in mouse retina but not in the developing heart. J Cell Sci (2010) 0.83
Differentiation of mouse embryonic stem cells into cardiomyocytes via the hanging-drop and mass culture methods. Curr Protoc Stem Cell Biol (2010) 0.83
Influence of endostatin on embryonic vasculo- and angiogenesis. Dev Dyn (2004) 0.82
Endostatin down-regulates soluble guanylate cyclase (sGC) in endothelial cells in vivo: influence of endostatin on vascular endothelial growth factor (VEGF) signaling. Endothelium (2006) 0.82
S100A1 enhances the L-type Ca2+ current in embryonic mouse and neonatal rat ventricular cardiomyocytes. J Biol Chem (2005) 0.82
Optimization of magnetic nanoparticle-assisted lentiviral gene transfer. Pharm Res (2012) 0.82
NMR studies on the diffusion of hydrocarbons on the metal-organic framework material MOF-5. Angew Chem Int Ed Engl (2006) 0.82